
-
Akebia NASDAQ:AKBA Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts.
Location: 245 1st St, Massachusetts, 02142-1200, US | Website: akebia.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
581M
Cash
51.87M
Avg Qtr Burn
-10.16M
Short % of Float
7.19%
Insider Ownership
4.21%
Institutional Own.
27.33%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Auryxia (ferric citrate) Details Chronic kidney disease, Anemia, Kidney disease, Hyperphosphatemia | Approved Update | |
Vafseo™ (Vadadustat) Details Chronic kidney disease, Anemia, Kidney disease | Approved Quarterly sales | |
Vafseo™ (Vadadustat) Details Chronic kidney disease, Anemia, Kidney disease | Phase 3 Initiation |